ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2009;87:1557. doi:10.1016/j.athoracsur.2009.02.085
© 2009 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hyun-Sung Lee
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, H.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, H.-S.
Related Collections
Right arrow Pleura
Right arrowRelated Article

Original Articles: General Thoracic

Invited Commentary

Hyun-Sung Lee, MD, PhD

Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, 111 Jungbalsan-ro, Ilsandong-gu, Goyang, Gyeonggi 410-769, Korea

(Email: thoracic@ncc.re.kr).

The first 20% of the full text of this article appears below.

I read with interest the article by Yan and colleagues [1]. Therapy of malignant pleural mesothelioma (MPM) has included chemotherapy, gene therapy, hyperthermia, immunotherapy, photodynamic therapy, radiation therapy, surgery, and supportive care. The effect of these various therapies for MPM on patient outcomes has been difficult to assess. At this moment, no therapy has been adequately shown to have any proven benefit in the treatment of MPM. The combination of complete surgery, being decortication or extrapleural pneumonectomy, in combination with hemithorax radiotherapy seems promising only in . . . [Full Text of this Article]


Related Article

Prognostic Features of Long-term Survivors After Surgical Management of Malignant Pleural Mesothelioma
Tristan D. Yan, Michael Boyer, Mo Mo Tin, Junyang Sim, Catherine Kennedy, Jocelyn McLean, Paul G. Bannon, and Brian C. McCaughan
Ann. Thorac. Surg. 2009 87: 1552-1556. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Eur J Cardiothorac SurgHome page
I. Florath, A. Albert, A. Boening, I. C. Ennker, and J. Ennker
Aortic valve replacement in octogenarians: identification of high-risk patients
Eur J Cardiothorac Surg, June 1, 2010; 37(6): 1304 - 1310.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.